ASACARD, A NOVEL ASPIRIN FORMULATION, CAUSES LESS ENDOSCOPIC DAMAGE THAN CONVENTIONAL ASPIRIN IN HEALTHY-VOLUNTEERS

Citation
Mt. Donnelly et al., ASACARD, A NOVEL ASPIRIN FORMULATION, CAUSES LESS ENDOSCOPIC DAMAGE THAN CONVENTIONAL ASPIRIN IN HEALTHY-VOLUNTEERS, Gut, 41, 1997, pp. 197-197
Citations number
NO
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
41
Year of publication
1997
Supplement
3
Pages
197 - 197
Database
ISI
SICI code
0017-5749(1997)41:<197:AANAFC>2.0.ZU;2-P